Advertisement

Pharmaceutical Chemistry Journal

, Volume 22, Issue 9, pp 649–661 | Cite as

Agents for treatment of carciovascular illnesses. III. Antianginal and cardiotonic agents (review)

  • S. S. Liberman
  • L. N. Yakhontov
Search for New Drugs
  • 16 Downloads

Keywords

Organic Chemistry Cardiotonic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature cited

  1. 1.
    M. A. Angarskaya and D. G. Kolesnikov, The Pharmacology of Cardiac Glycosides [in Russian], Kiev (1970), pp. 3–9.Google Scholar
  2. 2.
    S. V. Anichkov and N. S. Sapronov, The Pharmacology of the Heart and Blood Vessels [in Russian], Moscow (1984).Google Scholar
  3. 3.
    N. I. Afonskaya, O. B. Il'inskii, V. F. Kondalenko, et al., Byull. éksp. Biol., No. 12, 754–757 (1986).Google Scholar
  4. 4.
    S. Sh. Akhmedov, V. P. Pomerantsev, Yu. A. Vasyuk, et al., Cov. Med., No. 3, 44–50 (1985).Google Scholar
  5. 5.
    R. P. Belonot and I. M. Karaban', Vrach. Delo, No. 9, 67–69 (1980).Google Scholar
  6. 6.
    V. S. Volkov and V. P. Bratolyubov, Ter. Arkh.,58, No. 5, 124 (1986).Google Scholar
  7. 7.
    B. E. Vochtal and L. G. Lozinskii, Kardiologiya,10, No. 12, 29–34 (1970).Google Scholar
  8. 8.
    B. E. Vochtal and M. E. Slutskii, Cardiac Glycosides [in Russian], Moscow (1973).Google Scholar
  9. 9.
    P. A. Galenko-Yaroshevskii, M. V. Pokrovskii, and V. V. Skibukin, Farmakol. Toksikol., No. 5, 63–67 (1986).Google Scholar
  10. 10.
    N. B. Gambashidze, S. G. Kobaladze, B. Sh. Burdiashvili, et al., Kardiologiya,25, No. 9, 77–79 (1985).Google Scholar
  11. 11.
    V. S. Gasilin and B. A. Sidorenko, Stenocardia [in Russian], Moscow (1981).Google Scholar
  12. 12.
    V. S. Gasilin, Kardiologiya,26, No. 7, 5–8 (1986).Google Scholar
  13. 13.
    V. V. Gafarov, I. V. Serova, and S. S. Malyutina, Kardiologiya,27, No. 1, 34–38 (1987).Google Scholar
  14. 14.
    V. V. Gatsura and A. N. Kudrin, Cardiac Glycosides in the Complex Pharmacotherapy of Coronary Insufficiency [in Russian], Moscow (1983).Google Scholar
  15. 15.
    G. A. Dubova, R. G. Davydova, and G. A. Markova, Klin. Med., No. 10, 47–50 (1974).Google Scholar
  16. 16.
    I. P. Zamotaev, M. G. Venediktova, L. G. Lozinskii, et al., ibid., No. 6, 28–32 (1986).Google Scholar
  17. 17.
    R. M. Zaslavskaya and R. D. Zolotaya, Sov. Med., No. 3, 80–83 (1981).Google Scholar
  18. 18.
    N. V. Kaverina and G. A. Markova, Farmakol. Toksikol., No. 2, 173–177 (1975).Google Scholar
  19. 19.
    N. V. Kaverina, Yu. B. Rozonov, and G. G. Chichkanov, Modern Aspects of the Pharmacology of Antianginal Agents [in Russian], Moscow (1980).Google Scholar
  20. 20.
    O. V. Karkushko, A. T. Butenko, and V. B. Shatilo, Sov. Med., No. 8, 3–7 (1986).Google Scholar
  21. 21.
    E. I. Kinoshenko, Kardiologiya,25, No. 4, 116–120 (1985).Google Scholar
  22. 22.
    N. N. Kipshidze, G. é Chapidze, L. A. Marsagishvili, et al., ibid., No. 8, 40–42.Google Scholar
  23. 23.
    L. L. Kirichenko, F. V. Solov'eva, V. V. Smirnov, et al., Sov. Med., No. 1, 66–68 (1987).Google Scholar
  24. 24.
    “Clinical classification of ischemic heart disease,” Kardiologiya,24, No. 10, 111–113 (1984).Google Scholar
  25. 25.
    F. I. Komarov, L. I. Ol'binskaya, and O. A. Vartanova, Ter. Arkh.,55, No. 12, 106 (1983).Google Scholar
  26. 26.
    P. F. Litvitskii, L. I. Ol'binskaya, V. A. Sandrikov, et al., Kardiologiya,21, No. 4, 71–74 (1981).Google Scholar
  27. 27.
    N. A. Mazur, Klin. Med., No. 10, 34–39 (1984).Google Scholar
  28. 28.
    N. A. Mazur, Kardiologiya,25, No. 4, 5–11 (1985).Google Scholar
  29. 29.
    S. Yu. Martsevich and V. I. Metelitsa, Ter. Arkh.,53, No. 4, 16–18 (1981).Google Scholar
  30. 30.
    S. Yu. Martsevich and V. I. Metelitsa, Klin. Med., No. 6, 37–40 (1986).Google Scholar
  31. 31.
    M. D. Mashkovskii, Medicinals [in Russian], 9th edn., Vols. 1–2, Moscow (1984).Google Scholar
  32. 32.
    K. A. Merzon, Kardiologiya,26, No. 10, 120–125 (1986).Google Scholar
  33. 33.
    V. I. Metelitsa, Ter. Arkh.,46, No. 1, 14–26 (1974).Google Scholar
  34. 34.
    V. I. Metelitsa, L. S. Matveeva, G. A. Borisova, et al., Kardiologiya,15, No. 7, 48–51 (1975).Google Scholar
  35. 35.
    V. I. Metelitsa, A. B. Davydov, K. L. Savvateev, et al., Ter. Arkh.,62, No. 5, 54–59 (1980).Google Scholar
  36. 36.
    V. I. Metelitsa, S. Yu. Martsevich, V. K. Piotrovskii, et al., Kardiologiya,25, No. 11, 119–120 (1985).Google Scholar
  37. 37.
    V. I. Metelitsa, S. A. Nikolenko, S. Yu. Martsevich, et al., Ter. Arkh.,54, No. 1, 79–84 (1982); V. I. Metelitsa, S. Yu. Martsevich, O. S. Ryabokon', and A. A. Strel'tsov, ibid.,58, No. 3, 45–49 (1986).Google Scholar
  38. 38.
    V. I. Metelitsa, ibid.,58, No. 5, 132–137 (1986).Google Scholar
  39. 39.
    V. I. Metelitsa, Kardiologiya,27, No. 1, 5–10 (1987).Google Scholar
  40. 40.
    R. I. Mikunis, N. T. Bogach, V. K. Sarkova, et al., Klin. Med., No. 6, 33–36 (1986).Google Scholar
  41. 41.
    N. M. Mukharlyamov and V. Yu. Mareev, The Treatment of Chronic Coronary Insufficiency [in Russian], Moscow (1985).Google Scholar
  42. 42.
    L. A. Myasnikov, V. I. Metelitsa, R. A. Grigor'yants, and Yu. A. Krasnikov, Kardiologiya,8, No. 11, 89–97 (1968).Google Scholar
  43. 43.
    A. G. Odinets, B. Z. Simkhovich, A. A. Kimenis, and G. Ya. Dubur, Khim.-farm. Zh., No. 12, 1443–1451 (1986).Google Scholar
  44. 44.
    L. I. Ol'binskaya, Kardiologiya,23, No. 7, 5–11 (1983).Google Scholar
  45. 45.
    L. L. Orlov, A. M. Shinov, A. A. Sviridov, et al., Farmakol. Toksikol., No. 5, 80–84 (1986).Google Scholar
  46. 46.
    F. E. Ostanyuk, T. E. Dobrotvorskaya, and Kh. Al'khavami, Kardiologiya,26, No. 8, 82–83 (1986).Google Scholar
  47. 47.
    E. L. Penchenko, ibid., No. 7, 109–116.Google Scholar
  48. 48.
    A. Yu. Romakov, A. M. Sagirov, and V. M. Destyanichenko, Byull. Vses. Kardiol. Nauch. Tsentra, No. 2, 57–63 (1983).Google Scholar
  49. 49.
    A. Yu. Romakov, A. M. Sagirov, A. B. Sumarokov, and N. A. Mazur, Kardiologiya,25, No. 4, 41–44 (1985).Google Scholar
  50. 50.
    I. P. Saraotaev, M. G. Venediktova, L. G. Lozinskii, et al., Klin. Med., No. 6, 28–33 (1986).Google Scholar
  51. 51.
    R. S. Satoskar and S. D. Bandarkar, Pharmacology and Pharmacotherapy [Russian translation], 8th edn., Vol. 1, Moscow (1986), pp. 412–420.Google Scholar
  52. 52.
    I. N. Serova and N. N. Kuleshov, Kardiologiya,22, No. 2, 117 (1982).Google Scholar
  53. 53.
    B. A. Sidorenko, V. A. Koshechkin, V. T. Lupanov, et al., ibid.,26, No. 7, 8–11 (1986).Google Scholar
  54. 54.
    A. N. Tarasov, A. N. Mitropol'skii, Z. D. Shvartsman, et al., Ter. Arkh.,58, No. 6, 115–118 (1986).Google Scholar
  55. 55.
    A. V. Tokar' and I. V. Persidskii, Kardiologiya,26, No. 7, 116–119 (1986).Google Scholar
  56. 56.
    M. N. Turebaev, Sov. Med., No. 11, 94–96 (1981).Google Scholar
  57. 57.
    é. Sh. Khalfen, I. L. Shvarts, Yu. N. Shigin, et al., Kardiologiya,20, No. 10, 45–49 (1980).Google Scholar
  58. 58.
    I. B. Tsorin and G. G. Chichkanov, Byull. éksp. Biol., No. 11, 585–587 (1986).Google Scholar
  59. 59.
    E. I. Chazov and V. I. Metelitsa, Khim.-farm. Zh., No. 10, 3–12 (1979).Google Scholar
  60. 60.
    E. I. Chazov, Ter. Arkh.,58, No. 6, 7–11 (1986).Google Scholar
  61. 61.
    R. A. Charchoglyan, N. N. Esin, and G. E. Belozerov, Sov. Med., No. 5, 15–18 (1982).Google Scholar
  62. 62.
    I. S. Chekman and V. V. Tkachuk, Farmakol. Toksikol., No. 6, 5–15 (1984).Google Scholar
  63. 63.
    I. S. Chekman and V. V. Tkachuk, ibid., No. 6, 95–100 (1986).Google Scholar
  64. 64.
    G. G. Chichkanov and I. B. Tsorin, ibid., No. 1, 52–55.Google Scholar
  65. 65.
    I. K. Shkhvatsabaya, Ischemic Heart Disease [in Russian], Moscow (1975).Google Scholar
  66. 66.
    E. V. érina and S. D. Belyaev, Ter. Arkh.,52, No. 10, 51–57 (1980).Google Scholar
  67. 67.
    Kh. Kh. Yarullin, D. Khadzhaev, G. A. Penyazeva, et al., Klin. Med., No. 2, 62–69 (1972).Google Scholar
  68. 68.
    L. N. Yakhontov and S. S. Liberman, Khim.-farm. Zh., No. 11, 1306–1321 (1985).Google Scholar
  69. 69.
    L. N. Yakhontov and S. S. Liberman, ibid., No. 3, 269–286 (1987).Google Scholar
  70. 70.
    L. Abrams, Am. J. Cardiol.,56, 12–18 (1985).Google Scholar
  71. 71.
    F. Achenbach, R. Ziskoven, J. Wiemer, and O. Hauswirth, Arzneim.-Forsch.,34, 1743–1749 (1984).Google Scholar
  72. 72.
    J. Ahlner, K. L. Axelsson, and K. Bornfeld, Acta Pharmacol. (Kbh),59, Suppl. 6, 17–25 (1986).Google Scholar
  73. 73.
    K. E. Anderson, ibid.,58, Suppl. 2, 31–42.Google Scholar
  74. 74.
    A. Andrauni et al., Eur. J. Med. Chem. Chim. Ther.,19, 219 (1984).Google Scholar
  75. 75.
    Annual Drug Data Rep.,6, No. 1, 89 (1984).Google Scholar
  76. 76.
    ibid., No. 3, 235.Google Scholar
  77. 77.
    ibid., 245.Google Scholar
  78. 78.
    ibid., No. 4, 286.Google Scholar
  79. 79.
    ibid.,7, No. 1, 17 (1985).Google Scholar
  80. 80.
    ibid., No. 3, 155.Google Scholar
  81. 81.
    ibid.,8, No. 5, 457 (1986).Google Scholar
  82. 82.
    ibid., No. 6, 540.Google Scholar
  83. 83.
    J. Askholt and F. Nielsch-Kudst, Acta Pharmacol. (Kbh.),59, 17–26 (1986).Google Scholar
  84. 84.
    M. Blaustein, Trends Pharmacol. Sci.,6, 289–292 (1985).Google Scholar
  85. 85.
    U. Bonchet, Presse Med.,14, 986 (1985).Google Scholar
  86. 86.
    B. Bringh, K. Nademance, and M. Josephson, Drugs,32, 1–14 (1986).Google Scholar
  87. 87.
    J. A. Bristol and D. B. Evans, Annu. Rep. Med. Chem.,16, 83–102 (1981).Google Scholar
  88. 88.
    J. A. Bristol, I. Sircar, W. H. Mods, et al., J. Med. Chem.,27, 1099–1100 (1984).Google Scholar
  89. 89.
    W. Brügger, P. Imhof, P. Müller, et al., Eur. J. Clin. Pharmacol.,29, 331–336 (1985).Google Scholar
  90. 90.
    U. Ahshagen (ed.), Clinical Pharmacology of Antianginal Drugs, Berlin (1985).Google Scholar
  91. 91.
    C. Dalton, J. B. Quinn, C. R. Burkhart, et al., J. Pharmacol. Exp. Ther.,173. 270–276 (1970).Google Scholar
  92. 92.
    K. Delenk-Heyderenreich, G. Henkler, U. Keller, et al., Pharmazie,30, 745–757 (1985).Google Scholar
  93. 93.
    G. Droogmans, B. Himpens, and R. Castelly, Experientia (Basel),41, 895–900 (1985).Google Scholar
  94. 94.
    Drugs of the Future,6, No. 8, 459–461 (1981).Google Scholar
  95. 95.
    ibid.,7, No. 4, 279 (1982).Google Scholar
  96. 96.
    ibid., No. 6, 407.Google Scholar
  97. 97.
    ibid., No. 10, 757.Google Scholar
  98. 98.
    ibid.,8, No. 1, 43 (1983).Google Scholar
  99. 99.
    ibid.,9, No. 1, 32–33 (1984).Google Scholar
  100. 100.
    ibid., No. 4, 256.Google Scholar
  101. 101.
    ibid.,10, No. 1, 28 (1985).Google Scholar
  102. 102.
    ibid., No. 2, 106–107.Google Scholar
  103. 103.
    ibid., No. 4, 295–297.Google Scholar
  104. 104.
    ibid., No. 6, 449–450.Google Scholar
  105. 105.
    ibid., No. 7, 570–571.Google Scholar
  106. 106.
    ibid., No. 8, 628–630.Google Scholar
  107. 107.
    ibid., No. 9, 746–747.Google Scholar
  108. 108.
    ibid., No. 11, 907–908.Google Scholar
  109. 109.
    ibid., 922–925.Google Scholar
  110. 110.
    ibid., No. 12, 979–981.Google Scholar
  111. 111.
    ibid.,11, No. 3, 171 (1986).Google Scholar
  112. 112.
    ibid., No. 5, 377–379.Google Scholar
  113. 113.
    Drugs of Today,18, No. 9, 422 (1982).Google Scholar
  114. 114.
    Drugs of Today,21, No. 10, 447 (1985).Google Scholar
  115. 115.
    A. R. Farah and A. A. Alousi, Life Sci.,22, 1139–1148 (1978).Google Scholar
  116. 116.
    J. Gaska, Am. J. Pharm.,157. 49–64 (1985).Google Scholar
  117. 117.
    Ph. Godframinol, Acta Pharmacol. (Kbh.),58, Suppl. 2, 5–30 (1986).Google Scholar
  118. 118.
    J. Haiech, J. Cavodore, and C. Le Peuch, J. Pharmacol. (Paris),16, No. 3, 215–225 (1985).Google Scholar
  119. 119.
    M. Inoue, M. Hori, S. Nakajima, et al., Arzneim.-Forsch.,34, 355–359 (1984).Google Scholar
  120. 120.
    A. Jonathon, Am. J. Cardiol.,56, 12–18 (1985).Google Scholar
  121. 121.
    I. Knabe, Arch. Pharm. (Weinheim),33, 77 (1963).Google Scholar
  122. 122.
    H. Landmann and H. Lowe, Pharmazie,31, 169–172 (1986).Google Scholar
  123. 123.
    H. Rathore, A. H. From, Kh. Ahmed, et al., J. Med. Chem.,29, 1845–1852 (1986).Google Scholar
  124. 124.
    D. W. Robertson, E. E. Beedle, J. H. Krushinski, et al., ibid.,28, 717–727 (1985).Google Scholar
  125. 125.
    D. W. Robertson, J. H. Krushinski, E. E. Beedler, et al., ibid.,29, 1832–1840 (1986).Google Scholar
  126. 126.
    K. Sakai et al., J. Pharmacol. Exp. Ther.,227. 220–223 (1983).Google Scholar
  127. 127.
    M. Sakanashi, E. Tomomatsu, R. Fukai, et al., Arzneim.-Forsch.,29, 1530–1532 (1979).Google Scholar
  128. 128.
    J. S. Schroeder, I. H. Lamb, R. Ginsberg, et al., Am. J. Cardiol.,49, 533–537 (1982).Google Scholar
  129. 129.
    K. Schror and Ch. Thienermann, Br. J. Pharmacol.,87, 131–137 (1986).Google Scholar
  130. 130.
    T. Simizu, T. Osumi, K. Niimi, et al., J. Med. Chem.,34, 334–341 (1984).Google Scholar
  131. 131.
    I. Sircar, B. L. Duell, G. Bobonski, et al., J. Med. Chem.,28, 1405–1413 (1985).Google Scholar
  132. 132.
    A. Soward, G. Vanhaleweyk, and P. Serrugs, Drugs,32, 66–101 (1986).Google Scholar
  133. 133.
    M. Speeding, Arch. Pharmacol.,318, 234–240 (1982).Google Scholar
  134. 134.
    C. Spivack, S. Ocken, and W. Frishman, Drugs,25, 159–174 (1983).Google Scholar
  135. 135.
    H. Stahle, H. Daniel, W. Kobinger, et al., J. Med. Chem.,23, 1217–1222 (1980).Google Scholar
  136. 136.
    N. Taira, M. Endoh, T. Iijima, et al., Arzneim.-Forsch.,34, 347–355 (1984).Google Scholar
  137. 137.
    M. Tominga, E. Yo, H. Ogawa et al., Chem. Pharm Bull.,34, 682–693 (1986).Google Scholar
  138. 138.
    V. Udhoji and M. Heng, Am. J. Med.,76, 234–240 (1984).Google Scholar
  139. 139.
    P. L. Vaghy, D. Johnson, M. A. Matlib, et al., J. Biol. Chem.,25, 6000–6005 (1982).Google Scholar
  140. 140.
    A. Ward, R. N. Brogden, R. C. Heel, et al., Drugs,26, 468–502 (1983).Google Scholar
  141. 141.
    R. Ziskoven, J. Wiemer, and C. Achenbach, Arzneim.-Forsch.,33, 1106–1113 (1983).Google Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • S. S. Liberman
    • 1
  • L. N. Yakhontov
    • 1
  1. 1.S. Ordzhonikidze All-Union Scientific-Research Institute of Pharmaceutical ChemistryMoscow

Personalised recommendations